Biosimilar G-CSF (filgrastim) is effective for peripheral blood stem cell mobilization and non-cryopreserved autologous transplantation

MeSH terms

• Adolescent
• Adult
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Biosimilar Pharmaceuticals / pharmacology*
• Blood Cell Count
• Blood Preservation*
• Combined Modality Therapy
• Cost Savings
• Female
• Filgrastim
• Granulocyte Colony-Stimulating Factor / economics
• Granulocyte Colony-Stimulating Factor / pharmacology*
• Hematologic Neoplasms / blood
• Hematologic Neoplasms / drug therapy
• Hematologic Neoplasms / surgery
• Hematopoietic Stem Cell Mobilization* / economics
• Humans
• Leukapheresis
• Male
• Middle Aged
• Peripheral Blood Stem Cell Transplantation*
• Prospective Studies
• Recombinant Proteins / economics
• Recombinant Proteins / pharmacology
• Transplantation, Autologous
• Young Adult